Literature DB >> 32434937

MHC-Independent Thymic Selection of CD4 and CD8 Coreceptor Negative αβ T Cells.

Roxanne Collin1,2, Félix Lombard-Vadnais1,3, Erin E Hillhouse1, Marie-Ève Lebel1, Geneviève Chabot-Roy1, Heather J Melichar1,4, Sylvie Lesage5,2.   

Abstract

It is becoming increasingly clear that unconventional T cell subsets, such as NKT, γδ T, mucosal-associated invariant T, and CD8αα T cells, each play distinct roles in the immune response. Subsets of these cell types can lack both CD4 and CD8 coreceptor expression. Beyond these known subsets, we identify CD4-CD8-TCRαβ+, double-negative (DN) T cells, in mouse secondary lymphoid organs. DN T cells are a unique unconventional thymic-derived T cell subset. In contrast to CD5high DN thymocytes that preferentially yield TCRαβ+ CD8αα intestinal lymphocytes, we find that mature CD5low DN thymocytes are precursors to peripheral DN T cells. Using reporter mouse strains, we show that DN T cells transit through the immature CD4+CD8+ (double-positive) thymocyte stage. Moreover, we provide evidence that DN T cells can differentiate in MHC-deficient mice. Our study demonstrates that MHC-independent thymic selection can yield DN T cells that are distinct from NKT, γδ T, mucosal-associated invariant T, and CD8αα T cells.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32434937     DOI: 10.4049/jimmunol.2000156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

Review 1.  CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.

Authors:  Zhiheng Wu; Yu Zheng; Jin Sheng; Yicheng Han; Yanyan Yang; Hongming Pan; Junlin Yao
Journal:  Front Immunol       Date:  2022-02-10       Impact factor: 7.561

2.  NKG2D Enhances Double-Negative T Cell Regulation of B Cells.

Authors:  Shi-Hua Hu; Long-Hui Zhang; Jie Gao; Jing-Heng Guo; Xiao-Dong Xun; Xiao Xiang; Qian Cheng; Zhao Li; Ji-Ye Zhu
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.